SCHEMBL14224668

SCHEMBL14224668

CNc1ccc(OCCN2CCOCC2)cc1N

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
KDM4E B2RXH2 2/20 0.56
NPC1 O15118 3/20 0.56
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
LTA4H P09960 1/20 0.52
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA7 P43166 1/20 0.51
CA9 Q16790 1/20 0.51
RAB9A P51151 2/20 0.50
MAPK1 P28482 2/20 0.50
TBK1 Q9UHD2 1/20 0.50
CYP1A2 P05177 1/20 0.50
CHRM2 P08172 1/20 0.50
CHRM1 P11229 1/20 0.50
HTR2A P28223 1/20 0.50
SCN1A P35498 1/20 0.50
HTR2B P41595 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3383766 0.84 ALDH1A1 (0.65) ALDH1A1KDM4ENPC1MEN1KMT2A
SCHEMBL1605290 0.83 NPC1 (0.67) ALDH1A1KDM4ENPC1MEN1KMT2A
SCHEMBL21964480 0.81 ALDH1A1 (0.53) ALDH1A1KDM4ENPC1MEN1KMT2A
SCHEMBL12312257 0.81 ALDH1A1 (0.58) ALDH1A1KDM4ENPC1MEN1KMT2A
SCHEMBL2946059 0.80 NPC1 (0.71) ALDH1A1KDM4ENPC1MEN1KMT2A
SCHEMBL27038044 0.80 KDM4E (0.60) ALDH1A1KDM4ENPC1MEN1KMT2A
SCHEMBL20522213 0.80 KDM4E (0.60) ALDH1A1KDM4ENPC1MEN1KMT2A
SCHEMBL9939076 0.80 KDM4E (0.77) ALDH1A1KDM4ENPC1MEN1KMT2A
SCHEMBL25941894 0.80 ALDH1A1 (0.56) ALDH1A1KDM4ENPC1MEN1KMT2A
SCHEMBL113405 0.78 LTA4H (0.63) ALDH1A1KDM4ENPC1LTA4HCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS GENESOFT PHARMACEUTICALS, INC. (US) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS QTRT1, Q6ZSR9, QTRT2 ALDH1A1 2229/4885KDM4E 3096/4885NPC1 796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.